The 6th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held virtually and saw leading experts debate key questions on the optimization and role of transplantation and cellular therapies in the field of hematological malignancies.
View all videos

COSTEM 2021

The 6th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM)
21–24 October 2021 | Virtual Meeting

7/ Follow us along during #ASH21 #ASH21_MSKMM for comments on different abstract! #MedTwitter @kordeneha1 @LesokhinMD @UrviShahMD @CarlynRTanMD @MalinHultcrantz Drs. Hassoun, Malilankody & Maclachlan not on twitter @sloan_kettering @ASH_hematology @HemOncFellows

@szusmani @SLentzsch @jmikhaelmd @asgemrecan @MM_Hub For resource limited countries where access to CART or Bites are not possible an effective combination for Lenalidomide refractory patients is Daratumumab plus Carfilzomib https://authors.elsevier.com/c/1eBN~5EIIgECBd

Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic.

▶️Watch here: http://ow.ly/ZBUs50GZF3e

@iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

Ernst Holler of @uni_regensburg summarizes recent research on biomarkers and prognostication for #GvHD.

👉Watch here: http://ow.ly/MTig50GZEHP👈

@COSTEMCongress #COSTEM21 #GvHD #HemOnc

🏆 The Inaugural Pelotonia Impact Awards 🏆

Award 5️⃣ (the final award!) is the Pelotonia-Funded Researcher of the Year Award.

Let's cheer on our winner: Dr. Jennifer Woyach, a hematologist-oncologist at @OSUCCC_James 🎊

Load More...

COSTEM 2021

The 6th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM)
21–24 October 2021 | Virtual Meeting
The 6th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held virtually and saw leading experts debate key questions on the optimization and role of transplantation and cellular therapies in the field of hematological malignancies.
View all videos

7/ Follow us along during #ASH21 #ASH21_MSKMM for comments on different abstract! #MedTwitter @kordeneha1 @LesokhinMD @UrviShahMD @CarlynRTanMD @MalinHultcrantz Drs. Hassoun, Malilankody & Maclachlan not on twitter @sloan_kettering @ASH_hematology @HemOncFellows

@szusmani @SLentzsch @jmikhaelmd @asgemrecan @MM_Hub For resource limited countries where access to CART or Bites are not possible an effective combination for Lenalidomide refractory patients is Daratumumab plus Carfilzomib https://authors.elsevier.com/c/1eBN~5EIIgECBd

Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic.

▶️Watch here: http://ow.ly/ZBUs50GZF3e

@iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

Ernst Holler of @uni_regensburg summarizes recent research on biomarkers and prognostication for #GvHD.

👉Watch here: http://ow.ly/MTig50GZEHP👈

@COSTEMCongress #COSTEM21 #GvHD #HemOnc

🏆 The Inaugural Pelotonia Impact Awards 🏆

Award 5️⃣ (the final award!) is the Pelotonia-Funded Researcher of the Year Award.

Let's cheer on our winner: Dr. Jennifer Woyach, a hematologist-oncologist at @OSUCCC_James 🎊

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter